Dolati S, et al. Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators. Pharmacol Rep. 2018;70(6):1158–67.

Article  CAS  PubMed  Google Scholar 

Cummings J, et al. Drug development in Alzheimer’s disease: the path to 2025. Alzheimers Res Ther. 2016;8(1):39.

Article  PubMed  PubMed Central  Google Scholar 

Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005;115(6):1449–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang L-K, Chao S-P, Hu C-J. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci. 2020;27(1):1–13.

Article  Google Scholar 

Brookmeyer R, et al. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):186–91.

Article  PubMed  Google Scholar 

Prasad A. Physiological basis of memory dysfunction in Alzheimer’s disease–an overview. Int J Biochem Res Rev. 2020;29(2):9–24.

Article  Google Scholar 

Serrano-Pozo A, et al. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1(1):a006189.

Article  PubMed  PubMed Central  Google Scholar 

Hadavi D, Poot AA. Biomaterials for the treatment of Alzheimer’s disease. Front Bioeng Biotechnol. 2016;4: 49.

Article  PubMed  PubMed Central  Google Scholar 

Li L, et al. A selective degeneration of cholinergic neurons mediated by NRADD in an Alzheimer’s disease mouse model. Cell Insight. 2022;1(6):100060.

Article  PubMed  PubMed Central  Google Scholar 

Lee MK, Chen G. Loss of cholinergic and monoaminergic afferents in APPswe/PS1ΔE9 transgenic mouse model of cerebral amyloidosis preferentially occurs near amyloid plaques. Int J Mol Sci. 2024;25(9): 5004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allard S, Shuler MGH. Cholinergic reinforcement signaling is impaired by amyloidosis prior to its synaptic loss. J Neurosci. 2023;43(42):6988–7005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin CP, et al. Structural (dys) connectivity associates with cholinergic cell density in Alzheimer’s disease. Brain. 2022;145(8):2869–81.

Article  PubMed  PubMed Central  Google Scholar 

Alizadeh AM, et al. Encapsulation of curcumin in diblock copolymer micelles for cancer therapy. BioMed Res Int. 2015;2015(1):824746.

PubMed  PubMed Central  Google Scholar 

Wanninger S, et al. Metal complexes of curcumin–synthetic strategies, structures and medicinal applications. Chem Soc Rev. 2015;44(15):4986–5002.

Article  CAS  PubMed  Google Scholar 

Naksuriya O, et al. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35(10):3365–83.

Article  CAS  PubMed  Google Scholar 

Chakari-Khiavi F, et al. Prospects for the application of mesenchymal stem cells in Alzheimer’s disease treatment. Life Sci. 2019;231:116564.

Article  CAS  PubMed  Google Scholar 

Maity S, et al. Inhibition of amyloid fibril formation of β-lactoglobulin by natural and synthetic curcuminoids. New J Chem. 2018;42(23):19260–71.

Article  CAS  Google Scholar 

Hasanzadeh E, et al. Injectable hydrogels in central nervous system: unique and novel platforms for promoting extracellular matrix remodeling and tissue engineering. Mater Today Bio. 2023;20:100614.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jafarisavari Z, et al. Development of new nanofibrous nerve conduits by PCL-chitosan-hyaluronic acid containing Piracetam-Vitamin B12 for sciatic nerve: a rat model. Int J Pharm. 2024;655:123978.

Article  CAS  PubMed  Google Scholar 

Abpeikar Z, et al. Characterization of macroporous polycaprolactone/silk fibroin/gelatin/ascorbic acid composite scaffolds and in vivo results in a rabbit model for meniscus cartilage repair. Cartilage. 2021;13(2_suppl):1583S-1601S.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nadi A, et al. Fabrication of functional and nano-biocomposite scaffolds using strontium-doped bredigite nanoparticles/polycaprolactone/poly lactic acid via 3D printing for bone regeneration. Int J Biol Macromol. 2022;219:1319–36.

Article  CAS  PubMed  Google Scholar 

Abpeikar Z, et al. Development of meniscus cartilage using polycaprolactone and decellularized meniscus surface modified by gelatin, hyaluronic acid biomacromolecules: a rabbit model. Int J Biol Macromol. 2022;213:498–515.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amini N, et al. Fabrication and characterization of bilayer scaffolds made of decellularized dermis/nanofibrous collagen for healing of full-thickness wounds. Drug Deliv Transl Res. 2023;13(6):1766–79.

Article  CAS  PubMed  Google Scholar 

Yang Y. Nanofibrous scaffolds supporting optimal central nervous system regeneration: an evidence-based review. J Neurorestoratol. 20153:123-31.

Moeendarbary E, et al. The soft mechanical signature of glial scars in the central nervous system. Nat Commun. 2017;8(1): 14787.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood–brain barrier by nanoparticles. J Control Release. 2012;161(2):264–73.

Article  CAS  PubMed  Google Scholar 

Sensharma P, et al. Biomaterials and cells for neural tissue engineering: current choices. Mater Sci Eng C Mater Biol Appl. 2017;77:1302–15.

Article  CAS  PubMed  Google Scholar 

Asadpour S, et al. Natural biomacromolecule based composite scaffolds from silk fibroin, gelatin and chitosan toward tissue engineering applications. Int J Biol Macromol. 2020;154:1285–94.

Article  CAS  PubMed  Google Scholar 

Harley-Troxell ME, et al. Interactions of cells and biomaterials for nerve tissue engineering: polymers and fabrication. Polymers (Basel). 2023;15(18):3685.

Article  CAS  PubMed  Google Scholar 

Nosrati H, et al. Preparation and characterization of poly (ethylene oxide)/zinc oxide nanofibrous scaffold for chronic wound healing applications. Polymers in Medicine. 2020;50(1):41–51.

Article  PubMed  Google Scholar 

Ahmed EM. Hydrogel: preparation, characterization, and applications: a review. J Adv Res. 2015;6(2):105–21.

Article  CAS  PubMed  Google Scholar 

Huang Q, et al. Potential therapeutic natural compounds for the treatment of Alzheimer’s disease. Phytomedicine. 2024. https://doi.org/10.1016/j.phymed.2024.155822.

Article  PubMed  Google Scholar 

Niu C, Dong M, Niu Y. Natural polyphenol: their pathogenesis-targeting therapeutic potential in Alzheimer’s disease. Eur J Med Chem. 2024;269:116359.

Kim Y, Lim J, Oh J. Taming neuroinflammation in Alzheimer’s disease: the protective role of phytochemicals through the gut− brain axis. Biomed Pharmacother. 2024;178:117277.

Article  CAS  PubMed